Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2001 1
2005 1
2006 1
2007 1
2009 1
2010 2
2011 1
2012 5
2013 5
2014 2
2015 2
2016 3
2017 2
2018 10
2019 15
2020 11
2021 20
2022 27
2023 21
2024 21
2025 20
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean asukata y[au] (11 results)?
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: tsubata y. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Saito H, Fukuhara T, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Saito H, et al. Among authors: tsubata y. Lancet Oncol. 2019 May;20(5):625-635. doi: 10.1016/S1470-2045(19)30035-X. Epub 2019 Apr 8. Lancet Oncol. 2019. PMID: 30975627 Clinical Trial.
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis.
Fujisaki T, Miyauchi E, Kida G, Miura Y, Watanabe K, Ashinuma H, Tamiya M, Kikuchi H, Arai D, Takahashi S, Masuda K, Takigami A, Nagai Y, Miyawaki T, Tsubata Y, Nakao A, Masubuchi K, Nishiyama K, Watanabe S, Morita S, Maemondo M. Fujisaki T, et al. Among authors: tsubata y. Lung Cancer. 2025 Jul;205:108597. doi: 10.1016/j.lungcan.2025.108597. Epub 2025 May 27. Lung Cancer. 2025. PMID: 40480013 Free article.
Prolonged Edoxaban in Patients With Low Body Weight and Cancer-Associated Isolated Distal Deep Vein Thrombosis.
Nagai T, Nakanishi N, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Kim K, Ikeda S, Kimura T, Matoba S; ONCO DVT Study Investigators. Nagai T, et al. Among authors: tsubata y. JACC Adv. 2025 Aug;4(8):101956. doi: 10.1016/j.jacadv.2025.101956. Epub 2025 Jul 4. JACC Adv. 2025. PMID: 40616931 Free PMC article.
Palm Pustules Induced by Pemetrexed.
Nakashima K, Tsubata Y, Niihara H, Araki A, Isobe T. Nakashima K, et al. Among authors: tsubata y. J Thorac Oncol. 2021 Sep;16(9):1589-1591. doi: 10.1016/j.jtho.2021.06.021. Epub 2021 Jul 6. J Thorac Oncol. 2021. PMID: 34242787 Free article. No abstract available.
Lipoid Pneumonia Caused by Esophageal Achalasia.
Kono K, Hamaguchi M, Tanino A, Nakao M, Hotta T, Amano Y, Kurimoto N, Tsubata Y, Isobe T. Kono K, et al. Among authors: tsubata y. Intern Med. 2024 Feb 1;63(3):443-446. doi: 10.2169/internalmedicine.1891-23. Epub 2023 Jun 21. Intern Med. 2024. PMID: 37344432 Free PMC article.
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT Study.
Ogihara Y, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Sato T, Kimura T, Dohi K; ONCO DVT Study Investigators. Ogihara Y, et al. Among authors: tsubata y. Res Pract Thromb Haemost. 2025 Mar 6;9(2):102722. doi: 10.1016/j.rpth.2025.102722. eCollection 2025 Feb. Res Pract Thromb Haemost. 2025. PMID: 40224278 Free PMC article.
Multiple Mass Lesions in Pneumocystis Pneumonia.
Kobayashi M, Tsubata Y, Shiratsuki Y, Hotta T, Isobe T. Kobayashi M, et al. Among authors: tsubata y. Cureus. 2022 Jan 25;14(1):e21590. doi: 10.7759/cureus.21590. eCollection 2022 Jan. Cureus. 2022. PMID: 35228948 Free PMC article.
Impact of thrombocytopenia in patients with cancer-associated isolated distal deep vein thrombosis treated with edoxaban for 12 months versus 3 months: Insights from the ONCO DVT study.
Miyoshi Y, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Ono K, Kimura T; ONCO DVT Study Investigators. Miyoshi Y, et al. Among authors: tsubata y. Thromb Res. 2025 Sep;253:109419. doi: 10.1016/j.thromres.2025.109419. Epub 2025 Aug 6. Thromb Res. 2025. PMID: 40812137 No abstract available.
159 results